conclusion: the results of statistic analysis showed that the test and reference levofloxacin hydrochloride capsules were bioequivalent.

objective: to compare the pharmacokinetics and relative bioavailability of flunarizine capsule a ( bohai pharmaceutical, tangshan, lot no: 970901) and capsule b ( xichuan pharmaceutical, henan, lot no: 970129).

目的：比较两种国产盐酸氟桂利嗪胶囊在人体内的药物动力学及相对生物利用度。

be given flunarizine ( flunarizine hydrochloride capsules), 2 tablets/ time, 3 times/ day treatment.

给予西比灵（盐酸氟桂利嗪胶囊），2片/次，3次/日治疗。

comparison of the pharmacokinetics of norfloxacin injection and norfloxacin capsule in normal human volunteers

诺氟沙星注射剂和胶囊剂的人体药代动力学

the contents of 4 batches of norfloxacin capsule were 95.77%~ 98.74%.

测定4批诺氟沙星胶囊含量在95.77%～98.74%。

experimental research for making norfloxacin capsules by methed of stuffing after measuring and calculating

应用测定计算填充法制备诺氟沙星胶囊的实验研究

suggestions to present quality standard of norfloxacin capsules

对诺氟沙星胶囊现行质量标准的建议

objective to determine the content of norfloxacin capsule and evaluate its quality.

目的测定诺氟沙星胶囊含量，评价其质量。

determination of the content and dissolution in norfloxacin capsule

诺氟沙星胶囊含量及其溶出度的测定

determining the content and release rate of norfloxacin capsule by uv spectrometry

紫外分光光度法测定诺氟沙星胶囊的含量和溶出度紫外分光光度法测定诺氟沙星胶囊的含量

determination of the content of norfloxacin capsule by oscillographic chronopotentiometry

示波计时电位法测定诺氟沙星胶囊含量

study on dissolution rate and bioavailability of norfloxacin capsules

诺氟沙星胶囊溶出度及体内生物利用度研究

content determination of norfloxacin capsules by square wave polarography

方波极谱法测定诺氟沙星胶囊的含量

the relative bioavailability of the capsule was ( 98 ± 13)% to the reference tablet.

与进口罗红霉素片相比较，国产罗红霉素胶囊剂的相对生物利用度为（98±13）%。

comparisons between dissolutions of roxithromycin tablets ( capsules) from four producers

四厂家罗红霉素片剂（胶囊）溶出度比较

study on preparation of microcapsule roxithromycin and their performance parameters' evaluation

罗红霉素的微胶囊制备及缓释性能的研究

determination of the bioavailability of roxithromycin granule, capsule and tablet

罗红霉素颗粒剂、胶囊剂及片剂人体生物利用度测定

methods 20 male healthy subjects received a single dose of 150 mg roxithromycin enterosoluble capsules.

方法20名志愿者单剂量口服150mg的罗红霉素肠溶胶囊，采用LC-MS法测定其血清中罗红霉素浓度。

clinical pharmacokinetics and relative bioavailability of roxithromycin capsule

罗红霉素胶囊剂的临床药物动力学及相对生物利用度

study on pharmacokinetic and bioavailability of roxithromycin capsule and granule

罗红霉素胶囊剂和颗粒剂药代动力学和相对生物利用度研究

the relative bioavailability was 96.26% of roxithromycin capsule.

结论：罗红霉素胶囊与罗力得片为生物等效制剂，罗红霉素胶囊的相对生物利用度为96.26%。